| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/03/2011 | WO2011012256A1 Composition comprising alpha-lipoic acid and carnosine for treating the phantom limb syndrome |
| 02/03/2011 | WO2011012141A1 Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders |
| 02/03/2011 | WO2011012075A1 Substituted phenyl piperazinyl aralkylone derivatives and its application for preparing analgesic drugs |
| 02/03/2011 | WO2011011927A1 Use of rnf13 protein and encoding gene thereof in the preparation of medicaments for preventing and/or treating mental cognitive disorders |
| 02/03/2011 | WO2011011886A1 Compositions and methods for treating parkinson's disease |
| 02/03/2011 | WO2010133306A8 Process for the preparation of ibodutant (men15596) and related intermediates |
| 02/03/2011 | WO2010129276A3 PYRO-GLUTAMATE Aβ TARGETING AGENTS |
| 02/03/2011 | WO2010127878A3 Use of thiabendazole and derivatives thereof for the theraphy of neurological conditions |
| 02/03/2011 | WO2010124042A3 Modulators of 5-ht receptors and methods of use thereof |
| 02/03/2011 | WO2010119078A9 Indole derivative modulators of the alpha 7 nachr |
| 02/03/2011 | WO2010111136A9 Aliskiren modulation of neurogenesis |
| 02/03/2011 | WO2010100650A4 Therapeutic uses of mastic gum fractions |
| 02/03/2011 | WO2010077988A3 Role of proline rich peptides in cellular communication mechanisms and treatment of diseases |
| 02/03/2011 | WO2010000089A8 Stat3 and tyk2 as drug targets for neurodegenerative diseases |
| 02/03/2011 | US20110028742 Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 02/03/2011 | US20110028562 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use |
| 02/03/2011 | US20110028556 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | US20110028549 Use of a monoterpene to treat or prevent stress |
| 02/03/2011 | US20110028544 Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| 02/03/2011 | US20110028537 Somatic cell reprogramming |
| 02/03/2011 | US20110028531 Novel sirna compounds for inhibiting rtp801 |
| 02/03/2011 | US20110028527 Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgamma |
| 02/03/2011 | US20110028523 Selective Alpha 2B/2C Agonists |
| 02/03/2011 | US20110028520 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 02/03/2011 | US20110028519 Small molecule insulin mimetics absent quinones |
| 02/03/2011 | US20110028513 Method for treating neurological disorders with imidazolium and imidazolinium compounds |
| 02/03/2011 | US20110028509 Sulfonamides |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028496 Deuterium-enriched pyrimidine compounds and derivatives |
| 02/03/2011 | US20110028490 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake in-hibitors |
| 02/03/2011 | US20110028486 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7 |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028483 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 02/03/2011 | US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028478 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028475 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 02/03/2011 | US20110028472 Thienopyrimidines |
| 02/03/2011 | US20110028470 Detection and Treatment of Schizophrenia |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028457 Pharmaceutical preparation comprising permethylated cyclodextrin |
| 02/03/2011 | US20110028453 Treating Negative Symptoms of Schizophrenia Associated with Defective Neuregulin 1 |
| 02/03/2011 | US20110028448 Pyridine compounds |
| 02/03/2011 | US20110028442 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
| 02/03/2011 | US20110028441 Novel phenyl-substituted piperazino-dihydrothienopyrimidines |
| 02/03/2011 | US20110028437 Phosphorylated pyrone analogs and methods |
| 02/03/2011 | US20110028434 Long-chain polyunsaturated fatty acids (lc-pufa) in maternal nutrition during pregnancy and lactation |
| 02/03/2011 | US20110028431 Oral mucoadhesive dosage form |
| 02/03/2011 | US20110028418 Use of gabba receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness |
| 02/03/2011 | US20110028412 Herbal enhanced analgesic formulations |
| 02/03/2011 | US20110028402 Substance p-saporin (sp-sap) conjugates and methods of use |
| 02/03/2011 | US20110028401 Cripto blocking molecules and therapeutic uses thereof |
| 02/03/2011 | US20110028388 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110027455 Sequestering subunit and related compositions and methods |
| 02/03/2011 | US20110027397 Methods of treating autism spectrum disorders and compositions for same |
| 02/03/2011 | US20110027391 Liquid nucleotides/nucleosides-containing product |
| 02/03/2011 | US20110027389 Low Viscosity Liquid Polymeric Delivery System |
| 02/03/2011 | US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds |
| 02/03/2011 | US20110027371 Nanoparticulate statin formulations and novel statin combinations |
| 02/03/2011 | US20110027365 Patch Formulation For External Use |
| 02/03/2011 | US20110027360 Pharmacokinetics of s-adenosylmethionine formulations |
| 02/03/2011 | US20110027359 Novel Pharmaceutical Compositions Comprising Levetiracetam |
| 02/03/2011 | US20110027356 Combination of Oral Medicaments Bonded by a Wrapping |
| 02/03/2011 | US20110027354 Anti-parkinsonian compounds |
| 02/03/2011 | US20110027352 Compounds for use in the treatment of neuropathic pain |
| 02/03/2011 | US20110027351 Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions |
| 02/03/2011 | US20110027348 Composition and method inhibiting inflammation |
| 02/03/2011 | US20110027345 Composition containing rotigotine and use thereof and transdermal patch containing the composition |
| 02/03/2011 | US20110027342 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | US20110027325 Orally-administered agent |
| 02/03/2011 | US20110027324 O-desmethyl-venlafaxine for treating major depressive disorder |
| 02/03/2011 | US20110027305 Composition Comprising an Extract of Herbal Combination Thereof for Preventing and Treating Diabetes Mellitus |
| 02/03/2011 | US20110027301 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 02/03/2011 | US20110027288 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents |
| 02/03/2011 | US20110027284 Nogo-a binding molecules and pharmaceutical use thereof |
| 02/03/2011 | US20110027279 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 02/03/2011 | US20110027264 Gamma secretase modulators for the treatment of alzheimer's disease |
| 02/03/2011 | US20110027251 Novel uses for 4-phenylbutyrate (4pba) and its pharmaceutically acceptable salts |
| 02/03/2011 | US20110027220 Interleukin-1 Conjugates and Uses Thereof |
| 02/03/2011 | US20110027218 Tnf superfamily fusion proteins |
| 02/03/2011 | US20110027178 Imaging the central nervous system |
| 02/03/2011 | US20110023870 Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same |
| 02/03/2011 | CA2769429A1 Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders |
| 02/03/2011 | CA2769149A1 Compositions and methods for treating parkinson's disease |
| 02/03/2011 | CA2768527A1 Compounds - 801 |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/02/2011 | EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 02/02/2011 | EP2280022A1 Cripto blocking molecules and therapeutic uses thereof |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2280010A2 Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators |
| 02/02/2011 | EP2280008A2 Heterocyclic-substituted piperidines as ORL-1 ligands |
| 02/02/2011 | EP2279744A2 ApoE mimetic agents |
| 02/02/2011 | EP2279743A2 ApoE mimetic agents |
| 02/02/2011 | EP2279742A2 Combinations for the treatment of immunoinflammatory disorders |
| 02/02/2011 | EP2279741A2 Caprolactams and their use as anti-inflammatory agents |
| 02/02/2011 | EP2279740A1 Transdermal preparation |
| 02/02/2011 | EP2279739A1 Donepezil-containing patch preparation and packaging thereof |
| 02/02/2011 | EP2279738A1 The use of quaternary pyridinium salts as vasoprotective agents |
| 02/02/2011 | EP2279727A2 Nanoparticulate aripiprazole formulations |
| 02/02/2011 | EP2279532A2 Oxazolobenzimidazole derivatives |